UBS Group
EVLVW

UBS Group’s Evolv Technologies Warrant EVLVW Stock Holding History

UBS Group’s Portfolio EVLVW Stock Details EVLVW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-515
Closed -$376 – 10684
2025
Q3 		$376 Buy
+515
New +$360 ﹤0.01% 9711
2024
Q4 		– Sell
-163
Closed -$62 – 10051
2024
Q3 		$62 Sell
163
-120
-42% -$48 ﹤0.01% 9217
2024
Q2 		$76 Buy
+283
New +$102 ﹤0.01% 9196

Other funds holding EVLVW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return

UBS Group's EVLVW Position: Q4 2025 in Review

UBS Group sold out of Evolv Technologies Warrant (EVLVW) in Q4 2025, closing a stake of 515 shares — an estimated $376 sold.

UBS Group first reported a position in EVLVW in Q2 2024 and held it in 3 quarters. The position peaked at $376 in Q3 2025. 17 funds tracked by Wall St. Rank hold EVLVW as of Q4 2025.

  • UBS Group reported no remaining Evolv Technologies Warrant position as of Q4 2025 after selling out during the quarter.
  • UBS Group sold 515 Evolv Technologies Warrant shares in Q4 2025, an estimated $376.
  • UBS Group first reported a position in Evolv Technologies Warrant in Q2 2024 and held it in 3 quarters.
  • UBS Group's Evolv Technologies Warrant position peaked at $376 in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Evolv Technologies Warrant as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.